Offering

Americas Gold and Silver Corporation Announces Private Placement of up to C$6.5 Million

Retrieved on: 
Wednesday, March 20, 2024
Offering, Part, Sale, Toronto Stock Exchange, National instrument, American Market, TSX, Gold, Unit, USAS, Security (finance)

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- Americas Gold and Silver Corporation (TSX: USA, NYSE American: USAS) (the “Company”) is pleased to announce that it has entered into an agreement with Eight Capital, pursuant to which the Eight Capital has agreed to act as agent, on a “best efforts” basis, in connection with a private placement of up to 21,667,000 units of the Company (the “Units”) at a price of C$0.30 per Unit (the “Issue Price”) for gross proceeds of up to C$6,500,100 (the “Offering”).

Key Points: 
  • Each Unit will be comprised of one common share of the Company (each, a “Common Share”) and one common share purchase warrant of the Company (a “Warrant”).
  • Each Warrant will entitle the holder thereof to purchase one common share of the Company (each, a “Warrant Share”) at an exercise price of C$0.40 per Warrant Share for a period of 36 months following the closing of the Offering.
  • There is an offering document related to the Offering that can be accessed under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.americas-gold.com.
  • Prospective investors should read this offering document before making an investment decision.

Nevada Exploration Closes Oversubscribed $605,000 Financing

Retrieved on: 
Wednesday, March 20, 2024
Warrant, NGE, TSX Venture Exchange, Policy, Offering, Acceleration, Minority, Sale, News, Indian stock exchange, Multilateral, Security (finance)

The Offering is subject to final TSX Venture Exchange approval.

Key Points: 
  • The Offering is subject to final TSX Venture Exchange approval.
  • All securities issued are subject to a four month plus one day hold period expiring July 20, 2024, as well as to any other re-sale restrictions imposed by applicable securities regulatory authorities.
  • In connection with the Offering, the Company paid finders’ fees totalling $12,449.
  • Proceeds from the Offering will be used for general working capital.

Intelligent Group Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq

Retrieved on: 
Wednesday, March 20, 2024
Offering, Form, EDGAR, Sale, LLP, Prospectus, Suite, Security (finance)

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Intelligent Group Limited (Nasdaq: INTJ) (the “Company”), a Hong Kong based financial public relations company, today announced the pricing of its initial public offering (the “Offering”) of 1,875,000 ordinary shares (the “Ordinary Shares”), at a price of $4 per Ordinary Share.

Key Points: 
  • NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Intelligent Group Limited (Nasdaq: INTJ) (the “Company”), a Hong Kong based financial public relations company, today announced the pricing of its initial public offering (the “Offering”) of 1,875,000 ordinary shares (the “Ordinary Shares”), at a price of $4 per Ordinary Share.
  • Net proceeds to the Company, after deducting underwriting discounts, non-accountable expense allowance and offering expenses, are expected to be approximately $6.2 million.
  • WestPark Capital, Inc. is the sole Book-Running Manager for the Offering.
  • The Offering is being conducted pursuant to the Company’s Registration Statement on Form F-1 (File No.

SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT AND PROVIDES TRADING UPDATE

Retrieved on: 
Wednesday, March 20, 2024
EUR, Partner, Tax, DSR, Offering, Liver disease, FY, Ketel One, KBC, International, Committee, Financial services, 2.0, Cancer, Quality management system, AMERICA, Prospectus, Heart failure, FSMA, Person, European, EQT, LSP, PMA, US FDA, Overload, Stock, Marketing, Transaction, Security (finance)

(ii)   Finalizing the North American pivotal study in recurrent and refractory liver ascites (POSEIDON) towards secondary endpoint readout planned for Q2 2024.

Key Points: 
  • (ii)   Finalizing the North American pivotal study in recurrent and refractory liver ascites (POSEIDON) towards secondary endpoint readout planned for Q2 2024.
  • The Offering shall be structured as a private placement of new shares via an accelerated bookbuilding, which will commence immediately.
  • Trading in Sequana Medical shares on the regulated market of Euronext Brussels will be suspended during the bookbuilding period.
  • Trading in the shares is expected to resume following the publication of the results of the Offering.

Calibre Mining Announces C$100 Million Bought Deal Financing

Retrieved on: 
Tuesday, March 19, 2024
Indian stock exchange, Offering, Sale, News, Prospectus, TSX, CXB, OTCQX, BMO Capital Markets, Security (finance)

VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB, OTCQX: CXBMF) (the “Company” or “Calibre”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets, under which the underwriters have agreed to buy on bought deal basis 59,600,000 common shares (the “Common Shares”) of the Company, at a price of $1.68 per Common Share for gross proceeds of $100 million (the “Offering”). The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. The Offering is expected to close on or about April 16, 2024 and is subject to Calibre receiving all necessary regulatory approvals.

Key Points: 
  • Not for distribution to U.S. news wire services or dissemination in the United States.
  • VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB, OTCQX: CXBMF) (the “Company” or “Calibre”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets, under which the underwriters have agreed to buy on bought deal basis 59,600,000 common shares (the “Common Shares”) of the Company, at a price of $1.68 per Common Share for gross proceeds of $100 million (the “Offering”).
  • The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any.
  • The Offering is expected to close on or about April 16, 2024 and is subject to Calibre receiving all necessary regulatory approvals.

Landsea Homes Announces Pricing of Private Offering of Senior Notes

Retrieved on: 
Tuesday, March 19, 2024
Debt-to-GDP ratio, Surety, Person, Regulation, Sale, Offering, Security (finance)

DALLAS, March 19, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”) announced today that it has priced its previously announced offering (the “Offering”) of $300,000,000 of 8.875% Senior Notes due 2029 (the “Notes”).

Key Points: 
  • DALLAS, March 19, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”) announced today that it has priced its previously announced offering (the “Offering”) of $300,000,000 of 8.875% Senior Notes due 2029 (the “Notes”).
  • The Offering is expected to settle on or around April 1, 2024, subject to customary closing conditions.
  • The Company intends to use the net proceeds from the sale of the Notes to pay down a portion of the outstanding borrowings under its revolving credit facility.
  • An offer or solicitation to buy the Notes, if at all, will be made only by means of a confidential offering memorandum.

SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Tuesday, March 19, 2024
SLS, Madison Avenue, Offering, Form, Telephone, Research, Sale, Regulation D, Security (finance)

The warrants have an exercise price of $1.41 per share, are immediately exercisable upon issuance and will expire 5.5 years from issuance.

Key Points: 
  • The warrants have an exercise price of $1.41 per share, are immediately exercisable upon issuance and will expire 5.5 years from issuance.
  • The gross proceeds from the Offering are approximately $20 million, before deducting placement agent fees and other estimated Offering expenses.
  • The Company intends to use the net proceeds from the Offering for research and development activities, working capital and general corporate purposes.
  • Maxim Group LLC acted as a financial advisor to the Company in connection with the Offering.

RAMM Pharma Corp. Announces Corporate Update

Retrieved on: 
Tuesday, March 19, 2024
Indian stock exchange, Offering, Unit, Policy

TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”).

Key Points: 
  • TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”).
  • The proceeds from the Offering were expected to be used for working capital and general corporate purposes.
  • Ramm also announced its intention to commence a normal course issuer bid (the “NCIB”), under which it could have purchased up to 5% of the current number of issued and outstanding Common Shares.
  • Further reference to the proposed non-brokered private placement and the NCIB can be found on the Company’s announcement released on September 5th 2023.

Mattr Corp. Announces Pricing of Upsized Senior Unsecured Notes Offering

Retrieved on: 
Tuesday, March 19, 2024
TD Securities, Offering, Sale, Regulation, TSX, Conditional

TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it has entered into an underwriting agreement to sell, pursuant to a private placement offering (the “Offering”), C$175 million aggregate principal amount of 7.25% senior unsecured notes due 2031 (the “Notes”), which aggregate principal amount of notes was upsized from the initial deal size of C$150 million.

Key Points: 
  • TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today that it has entered into an underwriting agreement to sell, pursuant to a private placement offering (the “Offering”), C$175 million aggregate principal amount of 7.25% senior unsecured notes due 2031 (the “Notes”), which aggregate principal amount of notes was upsized from the initial deal size of C$150 million.
  • The Notes will be issued at a price of C$1,000 per C$1,000 principal amount of Notes.
  • “Over the last three years Mattr has completed a fundamental business transformation while delivering substantial growth and significantly strengthening our balance sheet.
  • Subject to customary closing conditions, the Offering is expected to close on or about April 2, 2024.

Greenridge Exploration Announces Closing of Private Placement for Gross Proceeds of CDN $3,500,455.12

Retrieved on: 
Monday, March 18, 2024
Warrant, Insider, Offering, Minority, GXP, Sale, News, Share (finance), Multilateral, NEWS, Person, Security (finance)

VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: HW3), is pleased to announce that is has closed its non-brokered private placement (the “Offering”) previously announced on February 5, 2024 and has issued 9,211,724 units (each, a “Unit”), at a price of $0.38 per Unit, for aggregate gross proceeds of $3,500,455.12. Each Unit is comprised of one common share of the Company (each, a “Share”) and one transferable common share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder to acquire one additional Share at an exercise price of $0.45 for a period of 24 months from the closing date. Finder's fees of $233,188.90 and 613,655 finder's warrants (the “Finder’s Warrants”) were paid to arm's length parties in connection with the Offering (each Finder's Warrant exercisable on the same terms as the Warrants forming part of the Units).

Key Points: 
  • Finder's fees of $233,188.90 and 613,655 finder's warrants (the “Finder’s Warrants”) were paid to arm's length parties in connection with the Offering (each Finder's Warrant exercisable on the same terms as the Warrants forming part of the Units).
  • The Company will use the proceeds from the Offering towards exploration on the Company’s Nut Lake and Weyman properties and for general working capital purposes.
  • The Company did not file a material change report in respect of the participation of the Insider in the Offering at least 21 days before closing of the Offering as the participation of the Insider was not determined at that time.
  • The Shares issued under the Offering will be subject to a statutory hold period expiring four months and one day from the date of issuance.